|
|
|
|
|
by namedgraph
1964 days ago
|
|
Yes RDF is in its own niche -- data interchange. And that's where merge matters, when you for example need to merge protein data with genes and drugs etc. A bunch of pharma companies are using RDF Knowledge Graphs for that purpose. The need for data interchange comes with a certain company size, and that point RDF becomes the solution because there are no real alternatives. I'm not talking about replacing JSON with RDF. Don't need data interchange -- don't use RDF. RDF is both at a different level of abstraction and solving problems of different scope. |
|
Could you perhaps recommend some industry case studies or publications on that specific problem area of biopharmaceuticals?